So far, cabotegravir LA has been approved in the US, Australia, Zimbabwe, South Africa, and Malawi, said GSK.
GSK has upgraded its longstanding alliance ... that it has signed a non-binding memorandum of understanding with South Africa-based Afrigen Biologics to support the development of an mRNA vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback